376 related articles for article (PubMed ID: 25041164)
1. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
Niemeijer ND; Alblas G; van Hulsteijn LT; Dekkers OM; Corssmit EP
Clin Endocrinol (Oxf); 2014 Nov; 81(5):642-51. PubMed ID: 25041164
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.
Huang H; Abraham J; Hung E; Averbuch S; Merino M; Steinberg SM; Pacak K; Fojo T
Cancer; 2008 Oct; 113(8):2020-8. PubMed ID: 18780317
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma.
Tanabe A; Naruse M; Nomura K; Tsuiki M; Tsumagari A; Ichihara A
Horm Cancer; 2013 Apr; 4(2):103-10. PubMed ID: 23361939
[TBL] [Abstract][Full Text] [Related]
4. Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.
Asai S; Katabami T; Tsuiki M; Tanaka Y; Naruse M
Horm Cancer; 2017 Apr; 8(2):108-118. PubMed ID: 28108930
[TBL] [Abstract][Full Text] [Related]
5. (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis.
van Hulsteijn LT; Niemeijer ND; Dekkers OM; Corssmit EP
Clin Endocrinol (Oxf); 2014 Apr; 80(4):487-501. PubMed ID: 24118038
[TBL] [Abstract][Full Text] [Related]
6. Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.
Jimenez P; Tatsui C; Jessop A; Thosani S; Jimenez C
Curr Oncol Rep; 2017 Oct; 19(12):83. PubMed ID: 29081018
[TBL] [Abstract][Full Text] [Related]
7. [A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine].
Naoi Y; Tamaki Y; Ooka M; Tsukamoto F; Miyoshi Y; Tanji Y; Taguchi T; Noguchi S
Gan To Kagaku Ryoho; 2003 Jan; 30(1):145-9. PubMed ID: 12557721
[TBL] [Abstract][Full Text] [Related]
8. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine.
Averbuch SD; Steakley CS; Young RC; Gelmann EP; Goldstein DS; Stull R; Keiser HR
Ann Intern Med; 1988 Aug; 109(4):267-73. PubMed ID: 3395037
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy.
Fujiwara Y; Ohmoto A; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Yuasa T; Yonese J; Takahashi S
Endocr J; 2021 Jun; 68(6):671-681. PubMed ID: 33518616
[TBL] [Abstract][Full Text] [Related]
10. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I
J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908
[TBL] [Abstract][Full Text] [Related]
11. Two cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine and dacarbazine in a combined chemotherapy.
Noshiro T; Honma H; Shimizu K; Kusakari T; Watanabe T; Akama H; Shibukawa S; Miura W; Abe K; Miura Y
Endocr J; 1996 Jun; 43(3):279-84. PubMed ID: 8886621
[TBL] [Abstract][Full Text] [Related]
12. Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia.
Tada K; Okuda Y; Yamashita K
Horm Res; 1998; 49(6):295-7. PubMed ID: 9623522
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy.
Nomura K; Kimura H; Shimizu S; Kodama H; Okamoto T; Obara T; Takano K
J Clin Endocrinol Metab; 2009 Aug; 94(8):2850-6. PubMed ID: 19470630
[TBL] [Abstract][Full Text] [Related]
14. Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
Wu LT; Dicpinigaitis P; Bruckner H; Manger W; Averbuch S
Med Pediatr Oncol; 1994; 22(6):389-92. PubMed ID: 8152400
[TBL] [Abstract][Full Text] [Related]
15. Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature.
Deutschbein T; Fassnacht M; Weismann D; Reincke M; Mann K; Petersenn S
Clin Endocrinol (Oxf); 2015 Jan; 82(1):84-90. PubMed ID: 25143180
[TBL] [Abstract][Full Text] [Related]
16. Treatment of malignant pheochromocytoma with combination chemotherapy.
Keiser HR; Goldstein DS; Wade JL; Douglas FL; Averbuch SD
Hypertension; 1985; 7(3 Pt 2):I18-24. PubMed ID: 3997232
[TBL] [Abstract][Full Text] [Related]
17. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
Hadoux J; Favier J; Scoazec JY; Leboulleux S; Al Ghuzlan A; Caramella C; Déandreis D; Borget I; Loriot C; Chougnet C; Letouzé E; Young J; Amar L; Bertherat J; Libé R; Dumont F; Deschamps F; Schlumberger M; Gimenez-Roqueplo AP; Baudin E
Int J Cancer; 2014 Dec; 135(11):2711-20. PubMed ID: 24752622
[TBL] [Abstract][Full Text] [Related]
18. Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Ilanchezhian M; Jha A; Pacak K; Del Rivero J
Curr Treat Options Oncol; 2020 Aug; 21(11):85. PubMed ID: 32862332
[TBL] [Abstract][Full Text] [Related]
19. [A case of malignant pheochromocytoma treated with a combination of cyclophosphamide, vincristine, and dacarbazine (CVD). A review of the Japanese literature of malignant pheochromocytoma treated with a combination of CVD].
Mizuno O
Nihon Naibunpi Gakkai Zasshi; 1994 Nov; 70(9):1039-46. PubMed ID: 7851622
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline.
Nakane M; Takahashi S; Sekine I; Fukui I; Koizumi M; Kage K; Ito Y; Aiba K; Horikoshi N; Hatake K; Ishikawa Y; Ogata E
Ann Oncol; 2003 Sep; 14(9):1449-51. PubMed ID: 12954587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
